Skip to main content
Springer Nature Link
Log in

Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The survival benefit of extended lymphadenectomy in the surgical treatment of gastric cancer is still being debated. The aim of this longitudinal multicenter study was to evaluate long-term survival in a group of patients with involvement of second level lymph nodes, which would not have been removed in the case of a limited lymphadenectomy. Results were compared with those in patients with involvement of first level lymph nodes.

Methods

Between 1991 and 1997, 451 patients with primary gastric cancer underwent curative resection with extended lymphadenectomy at three surgical departments in Italy according to the rules of the Japanese Research Society for Gastric Cancer.

Results

In 451 cases treated by extended lymphadenectomy, morbidity and mortality rates were 17.1% and 2%, respectively. In 126 patients (27.9%) (group A), metastases were found in lymph node stations 7 to 12; 109 patients (24.2%) had metastases confined to the first level (group B). Lymph node stations 7 and 8 showed the highest incidence of metastases in the second level (17.1% and 12.4%, respectively). A significant difference in 5-year survival was observed between group A and group B (32% vs. 54%;P=.0005). This difference disappeared when cases were stratified according to the number of positive lymph nodes. By multivariate analysis, only the number of positive lymph nodes (relative risk, 1.8;P<.0001) and the depth of invasion (relative risk. 2.1;P<.0001), but not the level of involved nodes, showed to be independent predictors of poor prognosis.

Conclusions

Japanese-type extended lymphadenectomy yields low morbidity and mortality rates if performed in specialized centers. This procedure could provide a good probability of long-term survival, even for patients with involvement of regional lymph nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wanebo HJ, Kennedy BJ, Chmiel J. Cancer of the stomach: a patient care study by the American College of Surgeons.Ann Surg 1993;218:583–92.

    Article  PubMed  CAS  Google Scholar 

  2. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.Cancer 1993;72:2089–97.

    Article  PubMed  CAS  Google Scholar 

  3. Maruyama K, Sasako M, Kinoshita T, et al. Should systematic lymph node dissection be recommended for gastric cancer?Eur J Cancer 1998;34:1480–9.

    Article  PubMed  CAS  Google Scholar 

  4. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality.World J Surg 1987;11:418–25.

    Article  PubMed  CAS  Google Scholar 

  5. Roukos DH, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.Surgery 1998;123:573–8.

    Article  PubMed  CAS  Google Scholar 

  6. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.Ann Surg 1998;228:449–61.

    Article  PubMed  CAS  Google Scholar 

  7. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients.Br J Surg 1993;80:1153–6.

    PubMed  CAS  Google Scholar 

  8. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group.N Engl J Med 1999;340:908–14.

    Article  PubMed  CAS  Google Scholar 

  9. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.Br J Cancer 1999;79:1522–30.

    Article  PubMed  CAS  Google Scholar 

  10. Japanese Research Society for Gastric Cancer.Japanese Classification of Gastric Carcinoma. Tokyo: Kaneara & Co., Ltd., 1995.

    Google Scholar 

  11. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma.Acta Pathol Microbiol Scand 1965;64:31–49.

    PubMed  CAS  Google Scholar 

  12. Sobin LH, Wittekind C.TNM Classification of Malignant Tumors. 5th ed. New York; John Wiley, 1997:59–62.

    Google Scholar 

  13. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.Cancer 1995;76:1302–12.

    Article  PubMed  CAS  Google Scholar 

  14. de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer.Br J Surg 1996;83:1604–7.

    PubMed  Google Scholar 

  15. Kasakura Y, Fujii M, Mochizuki F, Kochi M, Kaiga T. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer?Am J Surg 2000;179:237–42.

    Article  PubMed  CAS  Google Scholar 

  16. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.Hepatogastroenterology 2000; 47:579–85.

    PubMed  CAS  Google Scholar 

  17. Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients.Ann Surg 1989;210:596–602.

    Article  PubMed  CAS  Google Scholar 

  18. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.Br J Surg 1995;82:346–51.

    PubMed  CAS  Google Scholar 

  19. Hermanek P. PTNM and residual tumor classifications: problems of assessment and prognostic significance.World J Surg 1995;19: 184–90.

    Article  PubMed  CAS  Google Scholar 

  20. Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.Br J Surg 1996;83:1144–7.

    PubMed  CAS  Google Scholar 

  21. De Manzoni G, Verlato G, Guglielmi A, et al. Classification of lymph node metastases from carcinoma of the stomach: comparison of the old (1987) and new (1997) TNM systems.World J Surg 1999;23:664–9.

    Article  PubMed  Google Scholar 

  22. Hayashi H, Ochiai T, Suzuki T, Shimada H, Hori S, Takeda A, Miyazawa Y. Superiority of a new UICC-TNM staging system for gastric carcinoma.Surgery 2000;127:129–35.

    Article  PubMed  CAS  Google Scholar 

  23. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.Ann Surg 1998;228:347–54.

    Article  PubMed  CAS  Google Scholar 

  24. Fujimura T, Yonemura Y, Muraoka K, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study.World J Surg 1994;18:150–5.

    Article  Google Scholar 

  25. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.Cancer 1999;85:529–34.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Surgical Oncology, University of Siena, Via De Gasperi 5, 53100, Siena, Italy

    Franco Roviello MD & Daniele Marrelli MD

  2. Institute of Pathology, University of Siena, Via De Gasperi 5, 53100, Siena, Italy

    Carla Vindigni MD & Anna Tomezzoli MD

  3. First Department of Surgery, “Morgagni” Hospital of Forlì, Italy

    Paolo Morgagni MD

  4. First Division of General Surgery, University of Verona, Italy

    Giovanni de Manzoni MD & Alberto di Leo MD

  5. Unit of Pathology, “Pierantoni” Hospital of Forlì, Italy

    Luca Saragoni MD

  6. Department of Surgery, “Sacco” Hospital, University of Milano, Italy

    Hayato Kurihara MD

Authors
  1. Franco Roviello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniele Marrelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Morgagni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giovanni de Manzoni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alberto di Leo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carla Vindigni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luca Saragoni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anna Tomezzoli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hayato Kurihara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Italian Research Group for Gastric Cancer

Corresponding author

Correspondence to Franco Roviello MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roviello, F., Marrelli, D., Morgagni, P. et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study. Annals of Surgical Oncology 9, 894–900 (2002). https://doi.org/10.1007/BF02557527

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02557527

Key words

Search

Navigation